Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus
PHASE3CompletedINTERVENTIONAL
Enrollment
300
Participants
Timeline
Start Date
March 31, 1996
Conditions
Systemic Lupus Erythematosus
Interventions
DRUG
dehydroepiandrosterone
All Listed Sponsors
collaborator
Northwestern University
OTHER
lead
National Center for Research Resources (NCRR)
NIH
NCT00004662 - Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter